CASP9 and hepatocellular carcinoma: Compared to monotherapy, combination treatment markedly upregulated the expression levels of cleaved caspase 3 and cleaved caspase 9, suggesting that sorafenib combined with CuB treatment synergistically induced caspase‐dependent cell apoptosis in HCC cells.